Contracts Obtained by KEI via FOIA

Biomedical Advanced Research and Development Authority (BARDA) Agreements signed or expanded in 2020 to cover research on COVID-19 vaccines or therapeutics: AstraZeneca – vaccine. HHS/ASPR/BARDA-AstraZeneca Advanced Agreement to Other Transaction Authority Agreement 75A501-20-C-00114. May 20, 2020. HHS/ASPR/BARDA-AstraZeneca Modification of OTA… Continue Reading

Taxpayers are subsidizing 80 percent of Regeneron’s COVID-19 treatment’s R&D costs

Regeneron Pharmaceutical recently applied for Emergency Use Authorization of its investigational COVID-19 treatment, REGN-COV2, after Donald Trump said that it cured him of COVID-19, suggesting that Regeneron expects to cash in on the treatment. Taxpayers, however, are funding 80 percent… Continue Reading